Particular findings on lung CT in patients undergoing immunotherapy for bronchogenic carcinoma.

CONCLUSION: Management of patients with NSCLC using immune checkpoint inhibitors requires a knowledge of specific clinical and radiological findings. Both oncologists and radiologists have to be aware of the most common types, including atypical response patterns, such as a sarcoid-like reaction and pseudoprogression as well as of the pulmonary side effects that can encompass pneumonitis.
PMID: 32430613 [PubMed - as supplied by publisher]

Source: Wiener Klinische Wochenschrift - May 19, 2020 Category: General Medicine Authors: Beer L, Hochmair M, Kifjak D, Haug AR, Prayer F, Mayerhoefer ME, Herold C, Prosch H Tags: Wien Klin Wochenschr Source Type: research